Applied therapeutics to present at the 2022 annual clinical genetics meeting of the american college of molecular genetics and genomics

New york, march 16, 2022 (globe newswire) -- applied therapeutics, inc. (nasdaq: aplt), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced their abstract #op005 was accepted as an oral platform presentation at the 2022 annual clinical genetics meeting of the american college of molecular genetics and genomics, march 22 – 26, 2022 in nashville, tennessee.
APLT Ratings Summary
APLT Quant Ranking